
|Articles|November 1, 2002
Ablation method predictable, safe in small multicenter trial
Author(s)Lynda Charters
Nice, France-Preliminary data suggest that visual outcomes are excellent with the VISX WavePrint ablation method (VISX) for custom laser vision correction. At the European Society of Cataract and Refractive Surgery meeting, Douglas D. Koch, MD, described results of the VISX Study Group with 171 patients. He is professor of ophthalmology, The Allen, Mosbacher, and Law Chair in Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Houston.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves veligrotug-vvze (Lumvoa) for thyroid eye disease across active and chronic stages
2
Detecting peripheral retinal lesions in children with myopia
3
4DMT completes enrollment in 4FRONT-2, global phase 3 trial of 4D-150 in wet AMD
4
FDA grants priority review to Satralizumab sBLA for thyroid eye disease
5


























